CPhI Online is the largest global marketplace in the pharma ingredients industry
BLU PATENT V 2.5% S.A.L.F. (medical device)
Patent Blue V is a vital dye suitable for the marking
of the sentinel lymph node in breast cancer
and the intraoperative research of the sentinel
lymph node in patients with colon cancer. It is
also used in preoperative lymphoscintigraphy for
sentinel lymph node biopsy in melanoma.
Amber glass ampoule of 5 ml.
Amber glass ampoule of 2 ml.
Pre-filled PP syringe of 5 ml
with protective casing
Pre-filled PP syringe of 2 ml
with protective casing
2015On CPhI since
2015On CPhI since
More Products from S.A.L.F SpA
La metoclopramide stimola e coordina la motilità del tratto superiore dell’apparato gastroenterico, senza modificare la secrezione gastrica, pancreatica e biliare.Il suo meccanismo d’azione è complesso, essendo il farmaco antagonista competitivo dei recettori D1 e D2 (dopamina) e dei recettori 5-HT3 (serotonina), nonché agonista aspecifico dei recettori 5-HT4 coinvolti nella stimolazione dei neuroni colinergici enterici. Ha quindi attività procinetica intestinale, indipendente dall’innervazione vagale ma abolita da atropina e altri antagonisti muscarinici.Essa determina un aumento del tono e dell’ampiezza delle contrazioni gastroduodenali e, in misura progressivamente ridotta in senso distale, un incremento coordinato dei movimenti propulsivi del digiuno, dell’ileo e del colon, con una progressione periferica del contenuto endoluminale. Aumenta ancora il tono della muscolatura del terzo medio e inferiore dell’esofago e quindi la pressione a livello dello sfintere, rilasciando nel contempo piloro e bulbo duodenale. Queste azioni si traducono in un accelerato svuotamento gastrico e in una diminuzione del reflusso dal duodeno nello stomaco e nell’esofago. Confezionamento: Metoclopramide - astuccio 5 fiale da 2ml ,10mg/2ml.
Dopamine acts as an agonist on specific dopamine receptors and on alpha and beta adrenergic receptors. It decreases peripheral resistance and causes mesenteric and renal vasodilation. It increases renal blood flow, glomerular filtration and urinary flow. As regards the heart, dopamine causes an increased inotropism. It differs from noradrenaline in the action on the region of the kidneys and from isoproterenol, as it does not increase the heart rate. The knowledge about cardiovascular activities of dopamine involving the activation of alpha and beta adrenergic receptors, as well as dopaminergic receptors, allows to better modulate the amine infusion, which, depending on the dose, can give effects of vasoconstriction or vasodilation, cardiac stimulation, inhibition of the increase in heart rate, diuresis, natriuresis and inhibition of aldosterone circulation. SALF is also committed to the development of two new concentrations, 200mg/5ml and 400mg/5ml.
The solution is intended for perfusion and
hypothermic preservation of kidney, liver and
The solution kept bewween at 2° and 6° C (36°
-43° F) is used to spray the isolated organ
immediately before or immediately after its
removal from the dead donor or immediately
after its removal from the living donor.
The solution is then left in the vessels of
the organ during hypothermic storage and
transport. The solution should be used for the
cold storage of the organ and it is not suitable
for the hypothermic preservation with a
continuous machine perfusion.
The device can be used only by medical staff
properly trained to its use, in accordance with
established operating protocols.
AVAILABLE IN THE FOLLOWING
- Box containing 10 bags of 1000 ml.
- Box containing 5 bags of 2000 ml.
The solution is clear and colorless or light
The solution has a calculated osmolarity
of about 320 mosmol / l.
pH: 7.1 to 7.5 at 20 ° C.
The final concentration of sodium ions
is 29 mEq / l, of potassium ions is 125 mEq / l.
Pharmacotherapeutic group: Diuretics with a
major diuretic action.
Furosemide, a synthesis saluretic agent, causes
an increase in water and sodium elimination,
even in cases in which the glomerular filtration
is very limited.
The natriuretic effect is dose-dependent,
therefore, furosemide allows to obtain a guided
diuresis; instead, the urinary excretion of potassium
is significantly limited. As a result, the
sodium-potassium ratio is extremely favorable.
The diuretic effect following an oral administration
begins within the first hour and lasts 4-6
hours; by intravenous administration the effect
occurs within few minutes and lasts about 2
hours, while by intramuscular administration
the effect occurs a few minutes later, but the
duration of the action is longer.
Furosemide S.A.L.F. 250 mg/25 ml
solution for injection - 5 x 25 ml
vials A.I.C. 030671046 (Italian MA)
Furosemide S.A.L.F. 20 mg/2 ml
solution for injection - 5 x 2 ml
ampoules A.I.C. 030671010 (Italian MA)
S.A.L.F SpA resources
Position your company at the heart of the global Pharma industry with a CPhI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPhI events
An easy-to-use platform with a detailed dashboard showing your leads and performance